The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Adiponectin and Mortality in Patients with Chronic Kidney Disease
Abstract
Adiponectin is presumed to possess antiatherogenic and cardioprotective properties. Limited data exist on the relationship between adiponectin and mortality in the earlier stages of chronic kidney disease. The Modification of Diet in Renal Disease study was a randomized, controlled trial that was conducted between 1989 and 1993. Adiponectin was measured in frozen samples that were obtained at baseline (N = 820). Survival status and cause of death, up to December 31, 2000, were obtained from the National Death Index. Multivariable Cox models were used to examine the relationship of adiponectin with all-cause and cardiovascular mortality. Mean +/- SD age was 52 +/- 12 yr, and mean +/- SD glomerular filtration rate (GFR) rate was 33 +/- 12 ml/min per 1.73 m2. Eighty-five percent of participants were white, and 60% were male. Mean +/- SD adiponectin was 12.8 +/- 8.0 mug/ml. Triglycerides, insulin resistance, glucose, body mass index, GFR, C-reactive protein, and albumin were inversely related and proteinuria and HDL cholesterol were directly related to adiponectin. During the 10-year follow-up period, 201 (25%) participants died of any cause, and 122 (15%) from cardiovascular disease. In multivariable adjusted Cox models, a 1-mug/ml increase in adiponectin was associated with a 3% (hazard ratio 1.03; 95% confidence interval 1.01 to 1.05; P = 0.02) increased risk for all-cause and 6% (hazard ratio 1.06; 95% confidence interval 1.03 to 1.09; P < 0.001) increased risk for cardiovascular mortality. High, rather than low, adiponectin is associated with increased mortality in this cohort of patients with chronic kidney disease stages 3 to 4. Further studies are necessary to confirm this association and to elucidate the underlying mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Self-citationA Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041591798 · Cited by 1,985
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
Association of Hypoadiponectinemia With Coronary Artery Disease in Men
Kumada, M., Kihara, S., Sumitsuji, S., Kawamoto, T., Matsumoto, S., Ouchi, N., Arita, Y., Okamoto, Y., Shimomura, I., Hiraoka, H., et al. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000048856.22331.50 · Cited by 1,420
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients
Kalantar-Zadeh, K., Block, G., Humphreys, M. H., & Kopple, J. D. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00803.x · Cited by 1,247
Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311113200 · Cited by 1,163
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., & Scherer, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207198200 · Cited by 1,086
Adiponectin acts in the brain to decrease body weight
Qi, Y., Takahashi, N., Hileman, S. M., Patel, H. R., Berg, A. H., Pajvani, U. B., Scherer, P. E., & Ahima, R. S. (2004) · Nature Medicine · doi:10.1038/nm1029 · Cited by 809
The Obesity Paradox: Body Mass Index and Outcomes in Patients With Heart Failure
Curtis, J. P., Selter, J. G., Wang, Y., Rathore, S. S., Jovin, I. S., Jadbabaie, F., Kosiborod, M., Portnay, E. L., Sokol, S. I., Bader, F., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.1.55 · Cited by 809
Zoccali, C., Mallamaci, F., Tripepi, G., Benedetto, F. A., Cutrupi, S., Parlongo, S., Malatino, L. S., Bonanno, G., Seminara, G., Rapisarda, F., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v131134 · Cited by 761
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure
Kistorp, C., Faber, J., Galatius, S., Gustafsson, F., Frystyk, J., Flyvbjerg, A., & Hildebrandt, P. (2005) · Circulation · doi:10.1161/circulationaha.104.530972 · Cited by 605
Role of Disulfide Bonds in Acrp30/Adiponectin Structure and Signaling Specificity
Tsao, T.-S., Tomas, E., Murrey, H. E., Hug, C., Lee, D. H., Ruderman, N. B., Heuser, J. E., & Lodish, H. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309469200 · Cited by 473
Menon, V., Greene, T., Wang, X., Pereira, A. A., Marcovina, S. M., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Sarnak, M. J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00455.x · Cited by 417
Self-citationAdiponectin and Future Coronary Heart Disease Events Among Men With Type 2 Diabetes
Schulze, M. B., Shai, I., Rimm, E. B., Li, T., Rifai, N., & Hu, F. B. (2005) · Diabetes · doi:10.2337/diabetes.54.2.534 · Cited by 365 · cited 2×
“Low levels of adiponectin were associated with higher risk for incident coronary heart disease events in men with and without diabetes in the Health Professionals Follow-Up Study (5,6).”
BackgroundBecker, B., Kronenberg, F., Kielstein, J. T., Haller, H., Morath, C., Ritz, E., & Fliser, D. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090742 · Cited by 329
Association of body size with outcomes among patients beginning dialysis
Johansen, K. L., Young, B., Kaysen, G. A., & Chertow, G. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.324 · Cited by 283
Renal Pathology in Fabry Disease
Alroy, J., Sabnis, S., & Kopp, J. B. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000016684.07368.75 · Cited by 243
Schulze, M. B., Rimm, E. B., Shai, I., Rifai, N., & Hu, F. B. (2004) · Diabetes Care · doi:10.2337/diacare.27.7.1680 · Cited by 237
Mantzoros, C. S., Li, T., Manson, J. E., Meigs, J. B., & Hu, F. B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0372 · Cited by 224
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Frystyk, J., Tarnow, L., Krarup Hansen, T., Parving, H.-H., & Flyvbjerg, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1850-z · Cited by 223
Lawlor, D. A., Davey Smith, G., Ebrahim, S., Thompson, C., & Sattar, N. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0825 · Cited by 219
Stenvinkel, P., Marchlewska, A., Pecoits-Filho, R., Heimbürger, O., Zhang, Z., Hoff, C., Holmes, C., Axelsson, J., Arvidsson, S., Schalling, M., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00370.x · Cited by 183
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers
Rothenbacher, D., Brenner, H., März, W., & Koenig, W. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi340 · Cited by 174
Adiponectin and Coronary Heart Disease: The Strong Heart Study
Lindsay, R. S., Resnick, H. E., Zhu, J., Tun, M. L., Howard, B. V., Zhang, Y., Yeh, J., & Best, L. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000153090.21990.8c · Cited by 169
Adiponectin: Stability in Plasma over 36 Hours and Within-Person Variation over 1 Year
Pischon, T., Hotamışlıgil, G. S., & Rimm, E. B. (2003) · Clinical Chemistry · doi:10.1373/49.4.650 · Cited by 154
Plasma adiponectin concentration before and after successful kidney transplantation
Chudek, J. T., Adamczak, M., Karkoszka, H., Budziński, G., Ignacy, W., Funahashi, T., Matsuzawa, Y., Cierpka, L., Kokot, F., & Więcek, A. (2003) · Transplantation Proceedings · doi:10.1016/j.transproceed.2003.08.001 · Cited by 141
Bacci, S., Menzaghi, C., Ercolino, T., Ma, X., Rauseo, A., Salvemini, L., Vigna, C., Fanelli, R., Mario, U. D., Doria, A., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2015 · Cited by 136
Costacou, T., Zgibor, J. C., Evans, R. W., Otvos, J. D., Lopes-Virella, M. F., Tracy, R. P., & Orchard, T. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1597-y · Cited by 134
Serum Adiponectin Is Increased in Type 1 Diabetic Patients With Nephropathy
Saraheimo, M., Forsblom, C. M., Fagerudd, J. A., Teppo, A., Pettersson-Fernholm, K., Frystyk, J., Flyvbjerg, A., Groop, P., & on behalf of the FinnDiane Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1410 · Cited by 131
Looker, H. C., Krakoff, J. A., Funahashi, T., Matsuzawa, Y., Tanaka, S., Nelson, R. G., Knowler, W. C., Lindsay, R. S., & Hanson, R. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031916 · Cited by 130
Zoccali, C., Mallamaci, F., Panuccio, V. A., Tripepi, G. L., Cutrupi, S., Parlongo, S., Catalano, F., Tanaka, S., Ouchi, N., Kihara, S., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s84.49.x · Cited by 128
Huang, J., Yen, C., Chiang, H.-W., Hung, K., Tsai, T., & Wu, K. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.017 · Cited by 113
Hadjadj, S., Aubert, R., Fumeron, F., Péan, F., Tichet, J., Roussel, R., Marre, M., & groups, S. A. D. S. (2005) · Diabetologia · doi:10.1007/s00125-005-1747-x · Cited by 102
Adiponectin Is Inversely Associated with Renal Function in Type 1 Diabetic Patients
Schalkwijk, C. G., Chaturvedi, N., Schram, M. T., Fuller, J., & Stehouwer, C. D. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1117 · Cited by 94
Baseline characteristics in the Modification of Diet in Renal Disease Study.
Greene, T., Bourgoignie, J. J., Habwe, V. Q., Kusek, J. W., Snetselaar, L. G., Soucie, J. M., & Yamamoto, M. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v451221 · Cited by 61
Self-citation
Cited by
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases
Nigro, E., Scudiero, O., Monaco, M. L., Palmieri, A., Mazzarella, G., Costagliola, C., Bianco, A., & Daniele, A. (2014) · BioMed Research International · doi:10.1155/2014/658913 · Cited by 603
Stenvinkel, P., Carrero, J. J. A. A., Axelsson, J., Lindholm, B., Heimbu[Combining Diaeresis]rger, O., & Massy, Z. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03670807 · Cited by 561
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases
Choi, H. M., Doss, H. M., & Kim, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041219 · Cited by 510
Metadata
- Authors
- Menon, V., Li, L., Wang, X., Greene, T., Balakrishnan, V., Madero, M., Pereira, A. A., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Sarnak, M. J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2006-09
- Volume
- 17
- Issue
- 9
- Pages
- 2599-2606
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2123747735
- Cited by
- 283
- References
- 42
- FWCI
- 16.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.